Cantor Fitzgerald analysts initiated coverage of Acrivon Therapeutics Inc (NASDAQ:ACRV) with an Overweight rating. The initiation comes with a positive outlook on the company's potential in the ...

Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from ...

Donald Trump's commerce secretary nominee told his US Senate confirmation hearing Wednesday he favors "across-the-board" tariffs targeting countries rather than products, while signaling a hawkish ...

Donald Trump's commerce secretary nominee said Wednesday that he favors "across-the-board" tariffs and a country-based ...

Cantor Fitzgerald CEO and Commerce Secretary nominee Howard Lutnick became visibly emotional at his confirmation hearing ...

Cantor Fitzgerald initiated coverage of Nice (NICE) with a Neutral rating and $176 price target Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze ...

For exclusive news and updates, subscribe to our Survivor Newsletter: It’s been nearly 10 years since Michele Fitzgerald was crowned the winner of Survivor Season 32, but she’s still haunted ...

Cantor Fitzgerald raised the firm’s price target on Rubrik (RBRK) to $85 from $70 and keeps an Overweight rating on the shares. Rubrik has performed well since its April 2024 IPO, and its ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a look at where Varonis Systems, Inc. (NASDAQ:VRNS) stands against the ...

Cantor Fitzgerald analyst Deepak Mathivanan downgraded Sabre (SABR) to Neutral from Overweight with a price target of $4, down from $5, after assuming coverage of the name. Cantor expects fiscal ...